Compare LH & XYL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LH | XYL |
|---|---|---|
| Founded | 1971 | 2011 |
| Country | United States | United States |
| Employees | 70000 | N/A |
| Industry | Medical Specialities | Fluid Controls |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.9B | 25.0B |
| IPO Year | 2005 | 2011 |
| Metric | LH | XYL |
|---|---|---|
| Price | $324.86 | $108.81 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 13 |
| Target Price | ★ $311.33 | $152.50 |
| AVG Volume (30 Days) | 546.0K | ★ 1.6M |
| Earning Date | 04-30-2026 | 04-28-2026 |
| Dividend Yield | 1.12% | ★ 1.49% |
| EPS Growth | ★ 18.33 | 7.40 |
| EPS | ★ 6.99 | 1.90 |
| Revenue | ★ $13,951,700,000.00 | $9,035,000,000.00 |
| Revenue This Year | $8.26 | $2.79 |
| Revenue Next Year | $4.81 | $4.49 |
| P/E Ratio | ★ $46.77 | $55.63 |
| Revenue Growth | ★ 7.25 | 5.52 |
| 52 Week Low | $244.52 | $105.29 |
| 52 Week High | $341.80 | $154.27 |
| Indicator | LH | XYL |
|---|---|---|
| Relative Strength Index (RSI) | 55.25 | 40.29 |
| Support Level | $251.43 | $109.05 |
| Resistance Level | $341.80 | $112.75 |
| Average True Range (ATR) | 7.12 | 2.68 |
| MACD | -2.41 | -0.63 |
| Stochastic Oscillator | 35.42 | 32.05 |
Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from uncomplicated routine blood and urine screens to complex oncology and genomic testing.
Xylem is a global leader in water technology and offers a wide range of solutions, including the transport, treatment, testing, and efficient use of water for customers in the utility, industrial, commercial, and residential sectors. Xylem was spun off from ITT in 2011. Based in Rye Brook, New York, Xylem has a presence in over 150 countries and employs 16,200. The company generated $9 billion in revenue in 2025.